FDA approves IDE study to evaluate HeartWare Ventricular Assist System

pharma doctor

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its “ADVANCE” bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

Read more…

Light The White House Blue For Prostate Cancer Awareness Month

doc

Members of the Prostate Roundtable, consisting of America’s Leading Prostate Organizations, are asking President Obama to place a blue ribbon on the White House and light the White House blue in the evenings in recognition of Prostate Awareness Month in September. This visible show of support for prostate awareness by the White House will be a major tribute to the 2…

Read more…

Lupus Research Institute-Funded Study Points To Increased Risk For Lupus In Men

doctor

Lupus Research Institute-funded researcher Betty Tsao, PhD, at the University of California Los Angeles has discovered that humans - males in particular - with a variant form of the immune receptor “Toll Like Receptor 7 (TLR7)” are at increased risk of developing the autoimmune disease systemic lupus erythematosus (lupus)…

Read more…

Admitting Clinical Errors Not Always Best Policy

pharma doctors

(MedPage Today) — Wide-scale disclosure of clinical errors seems intuitively to be the ethical choice for hospitals and physicians, but researchers from the University of Washington suggest that disclosure should be decided on a case-by-case basis rather than a one-size-fits-all solution

Read more…

PTSD May Be Risk Factor for Dementia (CME/CE)

pharma doctor

(MedPage Today) — Older veterans with a history of post-traumatic disorder (PTSD) are at increased risk for developing dementia, even if they had not been wounded in battle, researchers found.

Read more…

Employees Pay More and Get Less from Medical Coverage

doctors

WASHINGTON (MedPage Today) — This year workers paid 14% more for their employer-sponsored healthcare coverage than they did last year as a bigger chunk of healthcare costs shifted from employers to employees, according to a new survey.

Read more…

More Americans Taking Rx Drugs (CME/CE)

doctors

(MedPage Today) — Nearly half of all Americans — 48% — took at least one prescription in a one-month period in 2007-2008, a four percentage point hike over a decade, researchers found.

Read more…

Tigecycline Label to Warn on Increased Death Risk

doctors

(MedPage Today) — A warning that the intravenous antibiotic tigecycline (Tygacil) is associated with increased risk of death, compared with other antibiotics, will be added to the product’s label, the FDA said.

Read more…

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

pharma doctors

As the summer comes to a close, I wanted to update you on the Company’s accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based vaccine product candidate.

Read more…

Data from ESC confirms reduction in adverse events with CYPHER Stent

pharma doctors

Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions

Read more…